Anika Therapeutics Inc ANIK
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ANIK is a good fit for your portfolio.
News
-
Anika Announces First Surgeries Performed using the Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Patch System for Rotator Cuff Repairs, Commencing Limited Market Release
-
Anika to Participate in Upcoming Investor Conferences
-
Anika Reports Third Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance on Growing Momentum Across the Business
-
Anika to Issue Third Quarter 2023 Financial Results on Thursday, November 2, 2023
-
Anika Announces the Full Market Release of the RevoMotion™ Reverse Shoulder Arthroplasty System during the 2023 Orthopaedic Summit: Evolving Technologies (OSET) Annual Meeting
-
Sidoti Events, LLC’s Virtual September Small-Cap Conference
-
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Anika to Participate in the Sidoti Small Cap Virtual Investor Conference
Trading Information
- Previous Close Price
- $22.74
- Day Range
- $21.90–22.92
- 52-Week Range
- $16.54–32.33
- Bid/Ask
- $21.94 / $21.99
- Market Cap
- $321.66 Mil
- Volume/Avg
- 45,462 / 203,526
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 2.04
- Dividend Yield
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Small Core
- Total Number of Employees
- 345
- Website
- https://www.anika.com
Valuation
|
Metric
|
ANIK
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 1.23 |
Price/Sales | 2.04 |
Price/Cash Flow | 47.36 |
Price/Earnings
ANIK
Financial Strength
|
Metric
|
ANIK
|
|---|---|
Quick Ratio | 3.75 |
Current Ratio | 5.59 |
Interest Coverage | — |
Quick Ratio
ANIK
Profitability
|
Metric
|
ANIK
|
|---|---|
Return on Assets (Normalized) | −2.27% |
Return on Equity (Normalized) | −2.76% |
Return on Invested Capital (Normalized) | −3.05% |
Return on Assets
ANIK
Medical Instruments & Supplies Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|
ISRG
| Intuitive Surgical Inc | Jmkk | $109.0 Bil | |
BDX
| Becton Dickinson & Co | Qgkpszq | $67.8 Bil | |
ALC
| Alcon Inc | Hwnqgnq | $35.5 Bil | |
CLPBY
| Coloplast A/S ADR | Qkx | $25.7 Bil | |
WST
| West Pharmaceutical Services Inc | Byb | $25.4 Bil | |
RMD
| ResMed Inc | Bbftz | $23.7 Bil | |
BAX
| Baxter International Inc | Clnvqh | $18.2 Bil | |
HOLX
| Hologic Inc | Zxkvlc | $16.6 Bil | |
COO
| The Cooper Companies Inc | Xjlynyn | $16.6 Bil | |
TFX
| Teleflex Inc | Zycpq | $10.7 Bil |